trending Market Intelligence /marketintelligence/en/news-insights/trending/4bxzm0EdnFHYmGK7NSg6zA2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

China Biologic to acquire 80% stake in PW Medtech unit

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


China Biologic to acquire 80% stake in PW Medtech unit

China Biologic Products Holdings Inc. said it will acquire PW Medtech Group Ltd.'s 80% equity interest in Tianxinfu (Beijing) Medical Appliance Co. Ltd.

China Biologic will issue 5,521,000 ordinary shares to PW Medtech in return for the equity in Tianxinfu. As a result, PWM will end up owning a 16.66% share in China Biologic.

The transaction is expected to close this year.

PW Medtech recently sold a 20% stake in Tianxinfu to Xinyu Yongshuo Management and Consulting LLP and was considering a spinoff and separate listing of the entity on the Shenzhen or Shanghai stock exchanges.